毕得医药
(688073)
| 流通市值：50.59亿 | | | 总市值：50.59亿 |
| 流通股本：9088.29万 | | | 总股本：9088.29万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 842,403,072.83 | 838,112,647.61 | 941,477,634.09 | 958,831,204.46 |
| 交易性金融资产 | 180,190,205.48 | 240,382,561.66 | 100,006,191.78 | 190,337,095.89 |
| 应收票据及应收账款 | 289,840,622.02 | 262,389,648.4 | 261,144,738.93 | 262,688,088.77 |
| 其中：应收票据 | 18,764,402.19 | 7,151,525.28 | 7,706,370.56 | 8,446,750.06 |
| 应收账款 | 271,076,219.83 | 255,238,123.12 | 253,438,368.37 | 254,241,338.71 |
| 预付款项 | 5,579,038.49 | 6,610,127.62 | 4,515,443.96 | 6,947,376.99 |
| 其他应收款合计 | 23,547,971.58 | 12,528,692.86 | 15,173,761.38 | 10,333,062.2 |
| 存货 | 934,656,541.48 | 966,603,499.27 | 962,006,646.47 | 925,588,830.8 |
| 其他流动资产 | 23,068,581.12 | 19,705,948.63 | 20,500,304.01 | 14,776,114.93 |
| 流动资产合计 | 2,299,286,033 | 2,346,333,126.05 | 2,304,824,720.62 | 2,369,501,774.04 |
| 非流动资产: | | | | |
| 固定资产 | 93,290,615.81 | 95,819,486.8 | 104,146,378.49 | 101,660,314.54 |
| 在建工程 | - | - | - | 3,237,154.14 |
| 使用权资产 | 42,027,824.13 | 45,522,280.46 | 48,869,624.57 | 40,611,622.91 |
| 无形资产 | 4,586,262.15 | 4,758,636.91 | 4,931,011.71 | 3,932,763.34 |
| 商誉 | 7,556,746.59 | 7,556,746.59 | 7,556,746.59 | - |
| 长期待摊费用 | 15,402,208.84 | 17,430,819.59 | 19,702,880.08 | 16,536,531.35 |
| 递延所得税资产 | 26,594,314.11 | 24,465,904.93 | 23,910,827.44 | 22,723,239.68 |
| 其他非流动资产 | 801,885.4 | 243,480 | 2,855,700 | 4,758,300 |
| 非流动资产合计 | 190,259,857.03 | 195,797,355.28 | 211,973,168.88 | 193,459,925.96 |
| 资产总计 | 2,489,545,890.03 | 2,542,130,481.33 | 2,516,797,889.5 | 2,562,961,700 |
| 流动负债: | | | | |
| 短期借款 | 5,038,466.12 | 137,099.4 | 341,215.45 | 191,490,038.52 |
| 应付票据及应付账款 | 157,998,040.15 | 164,690,232.79 | 202,459,565.65 | 230,649,576.75 |
| 其中：应付票据 | 500,000 | 500,000 | - | 37,479 |
| 应付账款 | 157,498,040.15 | 164,190,232.79 | 202,459,565.65 | 230,612,097.75 |
| 合同负债 | 52,823,570.58 | 46,376,117.46 | 48,310,248.85 | 37,524,178.96 |
| 应付职工薪酬 | 23,314,454.2 | 26,959,323.69 | 26,645,633.59 | 19,917,406.36 |
| 应交税费 | 44,184,979.02 | 55,749,028.48 | 37,069,777.67 | 26,894,789.46 |
| 其他应付款合计 | 47,376.56 | 82,069.92 | 2,353,901.31 | 47,726.45 |
| 一年内到期的非流动负债 | 19,088,884.27 | 16,479,628.28 | 19,155,063.98 | 9,657,032 |
| 其他流动负债 | 5,655,681.12 | 5,436,020.28 | 5,484,058.2 | 3,854,472.53 |
| 流动负债合计 | 308,151,452.02 | 315,909,520.3 | 341,819,464.7 | 520,035,221.03 |
| 非流动负债: | | | | |
| 长期借款 | 81,000,000 | 81,000,000 | 83,250,000 | - |
| 租赁负债 | 31,778,261.43 | 37,801,531.05 | 38,325,477.19 | 34,993,908.18 |
| 预计负债 | 70,438.2 | 74,499.37 | 70,702.92 | - |
| 递延所得税负债 | 6,716,191.29 | 7,377,388.18 | 7,937,239.31 | 5,470,204.36 |
| 非流动负债合计 | 119,564,890.92 | 126,253,418.6 | 129,583,419.42 | 40,464,112.54 |
| 负债合计 | 427,716,342.94 | 442,162,938.9 | 471,402,884.12 | 560,499,333.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 90,882,948 | 90,882,948 | 90,882,948 | 90,882,948 |
| 资本公积 | 1,801,268,929.78 | 1,797,311,817.67 | 1,792,610,870.38 | 1,786,715,528.16 |
| 减:库存股 | 199,984,541.27 | 199,984,541.27 | 199,984,541.27 | 199,984,541.27 |
| 其他综合收益 | 2,784,052.03 | 1,416,795.73 | -1,625,653.63 | -6,657,315.18 |
| 盈余公积 | 43,686,145.32 | 43,686,145.32 | 43,686,145.32 | 29,714,563.31 |
| 未分配利润 | 323,192,013.23 | 366,654,376.98 | 319,825,236.58 | 301,791,183.41 |
| 归属于母公司股东权益合计 | 2,061,829,547.09 | 2,099,967,542.43 | 2,045,395,005.38 | 2,002,462,366.43 |
| 股东权益合计 | 2,061,829,547.09 | 2,099,967,542.43 | 2,045,395,005.38 | 2,002,462,366.43 |
| 负债和股东权益合计 | 2,489,545,890.03 | 2,542,130,481.33 | 2,516,797,889.5 | 2,562,961,700 |
| 公告日期 | 2026-08-28 | 2026-04-30 | 2026-04-23 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |